Abstract The present application relates to a process for preparation of acalabrutinib or a pharmaceutically acceptable salt thereof. The present application also further relates an amorphous solid dispersion of acalabrutinib with one or more pharmaceutically acceptable carrier along with its process for preparation thereof.